535 related articles for article (PubMed ID: 24337009)
1. Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells.
Peng Y; Yang H; Wang N; Ouyang Y; Yi Y; Liao L; Shen H; Hu G; Wang Z; Tao L
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G253-63. PubMed ID: 24337009
[TBL] [Abstract][Full Text] [Related]
2. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways.
Peng Y; Yang H; Zhu T; Zhao M; Deng Y; Liu B; Shen H; Hu G; Wang Z; Tao L
Eur J Clin Invest; 2013 Apr; 43(4):358-68. PubMed ID: 23438945
[TBL] [Abstract][Full Text] [Related]
3. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways.
Fang L; Zhan S; Huang C; Cheng X; Lv X; Si H; Li J
Toxicol Appl Pharmacol; 2013 Nov; 272(3):713-25. PubMed ID: 23958495
[TBL] [Abstract][Full Text] [Related]
4. A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis.
Chen H; Gan Q; Yang C; Peng X; Qin J; Qiu S; Jiang Y; Tu S; He Y; Li S; Yang H; Tao L; Peng Y
J Transl Med; 2019 Aug; 17(1):280. PubMed ID: 31443720
[TBL] [Abstract][Full Text] [Related]
5. Fluorofenidone affects hepatic stellate cell activation in hepatic fibrosis by targeting the TGF-β1/Smad and MAPK signaling pathways.
Peng Y; Li L; Zhang X; Xie M; Yang C; Tu S; Shen H; Hu G; Tao L; Yang H
Exp Ther Med; 2019 Jul; 18(1):41-48. PubMed ID: 31258636
[TBL] [Abstract][Full Text] [Related]
6. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H
J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716
[TBL] [Abstract][Full Text] [Related]
7. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
[TBL] [Abstract][Full Text] [Related]
8. Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis.
Qin J; Xie YY; Huang L; Yuan QJ; Mei WJ; Yuan XN; Hu GY; Cheng GJ; Tao LJ; Peng ZZ
Nephrology (Carlton); 2013 Oct; 18(10):690-9. PubMed ID: 23841831
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
10. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S
Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
Zhao XY; Zeng X; Li XM; Wang TL; Wang BE
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596
[TBL] [Abstract][Full Text] [Related]
13. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
[TBL] [Abstract][Full Text] [Related]
14. Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats.
Li XW; Du J; Hu GY; Hu CP; Li D; Li YJ; Li XH
Can J Physiol Pharmacol; 2014 Jan; 92(1):58-69. PubMed ID: 24383874
[TBL] [Abstract][Full Text] [Related]
15. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
16. Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice.
Wang LH; Liu JS; Ning WB; Yuan QJ; Zhang FF; Peng ZZ; Lu MM; Luo RN; Fu X; Hu GY; Wang ZH; Tao LJ
Pharmacology; 2011; 88(1-2):88-99. PubMed ID: 21847000
[TBL] [Abstract][Full Text] [Related]
17. Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy
Peng X; Yang H; Tao L; Xiao J; Zeng Y; Shen Y; Yu X; Zhu F; Qin J
PeerJ; 2023; 11():e16060. PubMed ID: 37790613
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
[TBL] [Abstract][Full Text] [Related]
19. Fluorofenidone attenuates oxidative stress and renal fibrosis in obstructive nephropathy via blocking NOX2 (gp91phox) expression and inhibiting ERK/MAPK signaling pathway.
Qin J; Mei WJ; Xie YY; Huang L; Yuan QJ; Hu GY; Tao LJ; Peng ZZ
Kidney Blood Press Res; 2015; 40(1):89-99. PubMed ID: 26029782
[TBL] [Abstract][Full Text] [Related]
20. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells.
Klironomos S; Notas G; Sfakianaki O; Kiagiadaki F; Xidakis C; Kouroumalis E
Regul Pept; 2014 Jan; 188():5-12. PubMed ID: 24291170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
